V5 Aptamer Details
ID# 8187
Structure
Chemistry
DNA
Target
Ovarian cancer vessels
Category
Tissue
Affinity (Kd)
PBS with 5 mM MgCl2
Length
74
Aptazyme
No
Sequence (3-char table code)
G
A
C
U/T
5'-dCsdGsdCsdTsdCsdGsdGsdAsdTsdCsdGsdAsdTsdAsdAsdGsdCsdTsdTsdCsdGsdCsdAsdTsdAsdGsdAsdCsdCsdCsdAsdGsdCsdTsdGsdGsdTsdCsdCsdGsdGsdAsdAsdAsdAsdTsdAsdAsdGsdAsdTsdGsdTsdCsdAsdCsdGsdGsdAsdTsdCsdCsdTsdCsdTsdAsdGsdAsdGsdCsdAsdCsdTsdGs-3'
Molecular Weight: 22730.10
Extinction Coefficient: 719271
Binding Conditions / Buffer
37°C
Binding Temp: NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Refolding Protocol
If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Reference
Wang, Hongyu et al. “Morph-X-Select: Morphology-based tissue aptamer selection for ovarian cancer biomarker discovery.” BioTechniques vol. 61,5 249-259. 1 Nov. 2016, doi:10.2144/000114473
Request a Quote
Have your aptamer oligo synthesized by Aptagen.
